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Available online 17 March 2016Percutaneous coronary intervention (PCI) may be complicated by periprocedural myocardial infarction (PMI) as
manifested by elevated cardiac biomarkers such as creatine kinase (CK)-MB or troponin T. The occurrence of PMI
has been shown to be associatedwithworse short- and long-term clinical outcome. However, recent studies sug-
gest that PMI deﬁned by biomarker levels alone is a marker of atherosclerosis burden and procedural complexity
but inmost cases does not have independent prognostic signiﬁcance. Diagnostic multi-modality imaging such as
intravascular ultrasound, optical coherence tomography, coronary angioscopy, near-infrared spectroscopy,
multidetector computed tomography, and magnetic resonance imaging can be used to closely investigate the
atherosclerotic lesion in order to detectmorphologicalmarkers of unstable and vulnerable plaques in the patients
undergoing PCI. With the improvement of technical aspects of multimodality coronary imaging, clinical practice
and research are increasingly shifting toward deﬁning the clinical implication of plaquemorphology and patients
outcomes. There were numerous published data regarding the relationship between pre-PCI lesion subsets on
multi-modality imaging and post-PCI biomarker levels. In this review, we discuss the relationship between cor-
onary plaque morphology estimated by invasive or noninvasive coronary imaging and the occurrence of PMI.
Furthermore, this review underlies that the value of the multimodality coronary imaging approach will become
the gold standard for invasive or noninvasive prediction of PMI in clinical practice.
© 2016 TheAuthors. Published by Elsevier Ireland Ltd. This is an openaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Vulnerable plaque1. Introduction
Invasive coronary angiography (ICA) has been used as the gold stan-
dard for the diagnosis of coronary narrowing and clinical decision mak-
ing for coronary interventions. However, coronary angiography has
several limitations, including the substantial interpretation variability
of visual estimates and assessment of lesion severity for diffuse athero-
sclerotic lesions and intermediate-severity lesions [1,2]. Percutaneous
coronary intervention (PCI) has been one of the standard revasculariza-
tion procedures for patientswith signiﬁcant coronary artery disease. PCI
may be complicated by periprocedural myocardial infarction (PMI) as
manifested by elevated cardiac biomarkers such as creatine kinase
(CK)-MB or troponin T. The occurrence of PMI has been shown to be
associated with worse short- and long-term clinical outcome [3–5].
However, recent studies suggest that PMI deﬁned by biomarker levels
alone is a marker of atherosclerosis burden and procedural complexity
but in most cases does not have independent prognostic signiﬁcanceculty of Medicine, University of
land Ltd. This is an open access articl[6–8]. With the improvement of technical aspects of multimodality cor-
onary imaging, clinical practice and research are increasingly shifting
toward deﬁning the clinical implication of plaque morphology and pa-
tients' outcomes. In this review, we discuss the relationship between
coronary plaque morphology estimated by invasive or noninvasive cor-
onary imaging and the occurrence of PMI.
2. Periprocedural myocardial infarction after PCI
Cardiac troponin I (cTnI) and cTnT are the biomarkers of choice for the
diagnosis of myocardial damage, because they are the most sensitive and
cardiac-speciﬁc biomarkers currently available. The recently published
third universal deﬁnition ofMI attempts to provide some guidance by de-
ﬁning PMI in patients with normal (b99th percentile upper reference
limit (URL)) baseline cTn concentrations as an elevation of N5 × URL
within 48 h of the procedure together with either (i) evidence of
prolonged (N20min) ischaemia as demonstrated by chest pain; (ii) isch-
aemic ST changes or new pathological Q waves; (iii) angiographic evi-
dence of a ﬂow-limiting complication, such as of loss of patency of a
side branch, persistent slow-ﬂow or no-reﬂow, embolization; or (iv) im-
aging evidence of new loss of viable myocardium or new regional wall
motion abnormality [9]. Porto et al. found that the cause of periprocedurale under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Characteristics of various imagingmodalities for analysis of coronary plaque for the detec-
tion of PMI.
Modalities Images Characteristics of plaque
IVUS Grayscale: plaque burden, ruptured plaque,
attenuated plaque
VH: necrotic core area or volume
IB: lipid volume
iMAP: necrotic tissue volume
OCT Ruptured plaque
TCFA (large lipid core and a thin ﬁbrous cap)
Coronary
angioscopy
Intensive yellow plaque
Ruptured plaque
NIRS Lipid-core plaque (LCP) with a maxLCBI
(4 mm) ≧500
MDCT Low-attenuation, positive remodeling, spotty
calciﬁcation
Ring-like appearance
MRI High-intensity plaque detected in non-contrast
T1WI
PMI = periprocedural myocardial infarction, IVUS = intravascular ultrasound, VH =
virtual histology, IB = integrated backscatter, OCT = optical coherence tomography,
TCFA= thin-cap ﬁbroatheroma, CAS= coronary angioscopy, NIRS= near-infrared spec-
troscopy, LCBI= lipid core burden index,MDCT=multi-detector computed tomography,
MRI = magnetic resonance imaging.
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branches and distal embolization of atheromatous or thrombotic mate-
rials [10]. Park et al. have demonstrated that the side-branch occlusion
was the most common cause (57.3%) for the mechanism of PMI, and
other reasons included slow- or no-reﬂow, ﬂow-limiting dissection, and
distal embolization [11]. The slow-ﬂow, no re-ﬂow phenomenon, or
PMI after PCI has been associated with distal embolization, especially of
plaque debris, and with unfavorable clinical outcomes [12,13]. Therefore,
pre-PCI plaque composition on coronary imagingmay have an impact on
myocardial infarction during PCI (Table 1).Table 2
Coronary plaque characteristics on IVUS for prediction of PMI.
Author Number of patients Events rate (%)
Mehran et al. [14] 2256 CK-MB ≧ 1 × ULN (25.7%)
Fujii et al. [15] 62 CK-MB N 3 × ULN (15%)
Kawamoto et al. [16] 44 HITS with Doppler guidew
Hong et al. [17] 80 TnT N 3 × ULN (47.5%)
Uetani et al. [18] 114 TnT N 3 × ULN (11.4%)
Higuchi et al. [19] 33 TnT N 5 × ULN (36.3%)
Utunomiya et al. [20] 95 Slow ﬂow (11.6%)
PMI= periproceduralmyocardial infarction, CI= conﬁdence interval, IVUS= intravascular ult
virtual histology, IB = integrated backscatter.3. Invasive imaging for prediction of PMI
Diagnostic multi-modality imaging can be used to closely inves-
tigate the atherosclerotic lesion in order to detect morphological
markers of unstable and vulnerable plaques in the patients under-
going invasive coronary angiography and PCI. There were numer-
ous published data regarding the relationship between pre-PCI
lesion subsets on multi-modality imaging and post-PCI biomarker
levels.3.1. Intravascular ultrasound (IVUS) (Table 2)
IVUS is widely used to assess coronary artery morphometry. Virtual
histology (HV) IVUS, integrated backscatter (IB) IVUS, and iMAP IVUS
are available radio frequency analysis in clinical practice. Mehran et al.
[14] studied 2256 consecutive patients who underwent PCI of 2780
native coronary lesions and had pre-PCI IVUS imaging; both a greater
lesion and reference segment plaque burden were associated with
post-PCI creatine kinase-MB elevation. Fujii et al. [15] compared crea-
tine kinase-MB release after stent implantation in 62 patients with
IVUS-detected ruptured plaques with 62 matched control patients; pa-
tients with ruptured plaques had higher creatine kinase-MB release
rates than control patients, and independent predictors of post-PCI
creatine kinase-MB elevationwere presence of ruptured plaque and un-
stable angina. Grayscale IVUS has signiﬁcant limitations in assessing
plaque composition, and radiofrequency-derived histopathological
analysis by IVUS may provide quantitative information on plaque com-
position. VH-IVUS has demonstrated that large necrotic cores are relat-
ed to distal embolization and post-PCI cTn elevation [16,17]. The VH-
IVUS may play an important role in detecting which lesions are high
risks for myocardial necrosis after PCI. Uetani et al. [18] investigated
114 consecutive patients who received elective stent implantations fol-
lowing IB-IVUS analysis regarding the association between quantitative
analysis of the plaques of target lesions and the risk of post-procedural
myocardial injury after stenting. Lipid and ﬁbrous volumes correlated
with post-procedural cardiac biomarkers, and the lipid volume fraction
(lipid volume/total plaque volume) also correlated with post-
procedural TnT and CK-MB. Lipid volume and volume fraction were
concluded to be independent predictors of post-procedural myocardial
injury. The innovative radiofrequency-based analysis of tissue charac-
terization by IVUS (iMAP-IVUS) analyses also demonstrated that
necrotic tissue volume is a potent predictor of PMI [19]. In a study of
95 consecutive patients with stable angina or ACS patients with slow
ﬂow after PCI had signiﬁcantly higher absolute necrotic plaque volumes
(43.3 mm3 versus 20.1 mm3; P = 0.0004), as detected by iMAP IVUS
[20].Imaging result
Odds ratio
(95% CI)
Plaque burden 1.14 (1.07–1.82)
Ruptured plaque P= 0.03
ire N 12 (29.5%)
Necrotic core area
(VH, mm2)
4.41 (1.03–18.81)
Necrotic core area
(VH, mm2)
1.318 (1. 090–1.594)
Lipid volume
(IB, mm3)
0.011 (0.004–0.016)
Necrotic tissue volume
(iMAP, mm3)
1.026 (1. 004–1.048)
Necrotic plaque volume
(iMAP, mm3)
n/a
rasound, CK-MB= creatine kinase, ULN= upper limit of normal, TnT= troponin T, VH=
Table 3
Coronary plaque characteristics on OCT for prediction of PMI.
Author Number of patients Events rate (%) Imaging result
Odds ratio
(95% CI)
Yonetsu et al. [22] 125 CK-MB ≧ 1 × ULN (28%) TCFA 4.68 (1.88–11.64)
Lee et al. [23] 135 CK-MB ≧ 1 × ULN (26.7%) Ruptured plaque 2.92 (1.21–7.06)
Lee et al. [24] 131 TnI N 3 × ULN (23.7%) TCFA (b70 μm) 10.47 (3.74–29.28)
Lee et al. [25] 206 TnI N 5 × ULN (41%) TCFA (b70 μm) 2.89 (1.22–6.86)
Kini et al. [33] 110 TnI N 3 × ULN (9%) TCFA 0.896 (0.799–0.962)
TnI N 5 × ULN (7.3%) 0.907 (0.809–0.975)
PMI=periproceduralmyocardial infarction, CI= conﬁdence interval, IVUS= intravascular ultrasound, CK-MB=creatine kinase, ULN=upper limit of normal, TnI= troponin I, TCFA=
thin-cap ﬁbroatheroma.
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OCT is a high-resolution method for imaging plaque characteristics
(approximately 10-μ m resolution) and can be used to determine
ﬁbrous cap thickness and the presence of TCFA [21]. Yonetsu et al. [22]
demonstrated that the presence of OCT-derived TCFA (OR 4.68, 95% CI
1.88–11.64, P= 0.001) were independent predictors of post-PCI CK-MB
elevation. Lee et al. [23] demonstrated that IVUS-derived echo attenuation
(EA) (odds ratio [OR]: 3.49; 95% conﬁdence interval [CI]: 1.53 to 7.93; P=
0.003) and OCT-derived ruptured plaque (OR: 2.92; 95% CI: 1.21 to 7.06;
P = 0.017) were independent predictors of post-PCI CK-MB elevation.
Atherosclerotic plaqueswith EAwere associatedwith characteristics con-
sidered to be high risk or unstable. OCT examination showed an additive
predictive value to the presence of EA for post-PCI CK-MB elevation. They
also demonstrated that post-PCI MI (hazard ratio, 3.67; 95% conﬁdence
interval, 1.39 to 9.65; P = 0.009) and ejection fraction (hazard ratio,
0.96; 95% conﬁdence interval, 0.92 to 0.99; P=0.029) were independent
predictors of adverse cardiovascular events during follow-up, and the
presence of OCT-deﬁned thin-cap ﬁbroatheroma can predict post-PCI
MI in patients treated with elective stent implantation, who may require
adjunctive therapy after otherwise successful PCI [24]. More recently, Lee
et al. [25] demonstrated that the presence of subclinical cTnI elevation at
admission was not uncommon andwas associated with OCT-derived un-
stable plaque morphology in patients undergoing elective PCI, and may
help to identify patients with stable angina pectoris at high risk for
periprocedural myocardial injury.3.3. Coronary angioscopy (Table 4)
In 57 consecutive patients with NSTE-ACS who underwent
preinterventional angioscopy, the presence of coronary thrombus de-
tected with angioscopy to be the only independent factor associated
with elevated troponin T levels in patients with NSTE-ACS (odds ratio,
22.1; 95% CI, 2.59 to 188.42; P=0.0046) [26]. Mizote et al. demonstrat-
ed that no-reﬂow phenomenon was most frequently (P b 0.05) ob-
served in patients with angioscopically deﬁned ruptured plaque at
culprit lesion treated without distal protection in 81 AMI patients [27].
In 42 consecutive patients with stable angina undergoing elective
coronary stenting, coronary angioscopy demonstrated that intense
yellow culprit plaque coloration was closely associated with TnT eleva-
tion and ﬂow complications following elective coronary stenting.Table 4
Coronary plaque characteristics on coronary angioscopy for prediction of PMI.
Author Number of patients Events rate (%)
Okamatsu et al. [26] 57 TnT ≥ 0.1 ng/mL
Mizote et al. [27] 110 No/slow ﬂow (1
Murakami et al. [28] 42 TnT ≥ 0.03 ng/m
Transient no ﬂo
PMI = periprocedural myocardial infarction, CI = conﬁdence interval, TnT = troponin T.Angioscopically-observed intense yellow coloration may therefore pre-
dict high-risk plaque for periprocedural myocardial injury [28].
3.4. Near-infrared spectroscopy (NIRS) (Table 5)
Intracoronary NIRS was a method validated to rapidly identify coro-
nary lipid-core plaque (LCP) [29]. In a study of 30 patients undergoing
NIRS before PCI, CK-MB increase N3 timesULNwas observed in 27%of pa-
tients with N1 yellow block versus in none of the patients without a yel-
low block within the stented lesion (P= 0.02) [30]. Goldstein et al. [31]
analyzed the relationship between the presence of a large LCP (detected
byNIRS) and periproceduralMI. PeriproceduralMI occurred in 7 of 14 pa-
tients (50%) with a maxLCBI (lipid-core burden index) (4 mm) ≧500,
compared with 2 of 48 patients (4.2%) patients with a lower maxLCBI
(4mm) (P=0.0002). NIRS provides rapid, automated detection of exten-
sive LCPs that are associated with a high risk of periprocedural MI, pre-
sumably due to embolization of plaque contents during coronary
intervention. Recently, Kang et al. [32] demonstrated that NIRS-LRP was
more accurate than IVUS for predicting plaque containing a necrotic
core or a large lipid pool, and the combinationwasmore accurate than ei-
ther alone. Kini et al. reported that the direct comparison was made
amongOCT, IVUS, andNIRS in regard to relationship of parameter ﬁnding
and occurrence of PMI. They retrospectively analyzed 110 patients who
underwent OCT, IVUS, and NIRS, and demonstrated that OCT-based ﬁ-
brous cap thickness is themost important predictor of PMI. In the absence
of information about cap thickness, NIRS lipid core or IVUS plaque burden
best determined the likelihood of the periprocedural event [33]. Further-
more, Stone et al. examined that NIRS and IVUS were performed at base-
line, and lesions with a maximal lipid core burden index over any 4-mm
length (maxLCBI4 mm) ≧600were randomized to PCIwith versuswithout
a distal protection ﬁlter. Plaque characterization by NIRS identiﬁes lipid-
rich lesions with an increased likelihood of periprocedural MI after stent
implantation, presumably due to distal embolization. However, in this
pilot randomized CANARY Trial (Coronary Assessment by Near-infrared
of Atherosclerotic Rupture-prone Yellow), the use of a distal protection
ﬁlter did not prevent PMI after PCI of lipid-rich plaques [34].
4. Non-invasive imaging for prediction of PMI
With the development of multidetector computed tomography
(MDCT), it is possible not only to detect coronary artery stenosis butImaging result
Odds ratio
(95% CI)
(52%) Coronary thrombus 22.1(2.59 to 188.42)
9.4%) Ruptured plaque n/a
L (52%)
w (23%)
Intense yellow plaque 0.26 (2.25–1243.9)
Table 5
Coronary plaque characteristics on NIRS for prediction of PMI.
Author Number of patients Events rate (%) Imaging result
Odds ratio
(95% CI)
Raghunathan et al. [30] 30 CK-MB N 3 × ULN (10%) ≧12-mm yellow blocks n/a
Goldstein et al. [31] 62 TnI or CK-MB N 3 × ULN (14.5%) maxLCBI4 mm ≧ 500 12 (3.3–48)
Kini et al. [33] 110 TnI N 3 × ULN (9%)
TnI N 5 × ULN (7.3%)
maxLCBI4 mm 1.003 (1.000–1.006)
(All OCT ﬁndings excluded)
Stone et al. [34] 85 TnI or T N 3 × ULN (24.7%) maxLCBI4 mm ≧ 600 n/a
PMI= periprocedural myocardial infarction, CI= conﬁdence interval, CK-MB= creatine kinase, ULN=upper limit of normal, TnI= troponin I, NIRS= near-infrared spectroscopy, LCBI
= lipid core burden index.
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with IVUS and OCT [35,36]. Furthermore, the introduction of 256-slice,
320-detector scanner, and dual-source CT (DSCT) developed to signiﬁ-
cantly improve faster scan times,wider volume coverage, and high spatial
resolution [37]. In addition to MDCT, magnetic resonance imaging (MRI)
may also provide a noninvasive assessment of the risk for prediction of
PMI.
4.1. MDCT (Table 6)
There are several published data regarding the relation betweenpre-
PCI plaque composition byMDCT and post-PCI cardiac biomarker levels.
Nakagawa et al. reported that patients who experienced transient no-
reﬂow during PCI had lower plaque CT density values in culprit lesions
[38]. Uetani et al. demonstrated that post-procedural myocardial
injury was associated with the volume and fraction of low-attenuation
plaques by MDCT [39]. Our group showed that CT attenuation value of
b55 Hounsﬁeld units (HU) was associatedwith post-PCI cTnT elevation
[40]. Positive remodeling and spotty calciﬁcation were also signiﬁcant
predictors of post-PCI cTnT elevation. Furthermore, the presence of all
3 CT characteristics (CT attenuation value b55 HU, remodeling index
N1.05, and spotty calciﬁcation) showed a high positive predictive
value (PPV) of 94%, and their absence showed a high negative predictive
value (NPV) of 90%. Kodama et al. demonstrated that CTA-veriﬁed cir-
cumferential plaque calciﬁcation (CPC) with low-attenuation plaque
and positive remodeling were determinants of slow-ﬂow phenomenon
(SF) during PCI [41]. The conditional logistic regression analysis re-
vealed that CPC, plaque density, and dyslipidemia were the predictors
of SF, with CPC being the strongest (odds ratio: 79; 95% conﬁdence in-
terval: 8 to 783, P b 0.0001). These data suggest that it would beTable 6
Coronary plaque characteristics on MDCT for prediction of PMI.
Author Number of patients Events rate (%)
Nakazawa et al. [38] 51 Transient no ﬂow (17
Uetani et al. [39] 189 TnT N 3 × ULN (31.2%
Watabe et al. [40] 107 Transient no ﬂow (7.
TnT N 3 × ULN (33.6%
Kodama et al. [41] 40 Slow ﬂow (50%)
Nishio et al. [42] 55 Slow ﬂow (20%)
Values are presented as mean ± SD except as noted.
PMI = periprocedural myocardial infarction, MDCT = multi-detector computed tomogra
circumferential plaque calciﬁcation, n/a = not applicable, RI = remodeling index.
a Median and interquartile range.worthwhile to consider the identiﬁcation of these vulnerable plaques
by MDCT before PCI. If the plaque has the characteristics of low plaque
density, positive remodeling, and spotty calciﬁcation, a plan for preven-
tion of post-PCI cTnT elevation can be made before the PCI procedure.
Nishio et al. [42] showed that both ﬁndings of LAP and PR on MDCT
were highly sensitive for predicting plaque debris embolization.
4.2. MRI (Table 7)
Recently, non-contrast T1-weighted imaging (T1WI) has emerged as
a novel noninvasive imaging modality when searching for vulnerable
coronary plaque, and high-intensity plaque (HIP) detected in non-
contrast T1WI has been considered to be vulnerable coronary plaque
[43,44]. Asaumi et al. [45] published data on the association between
HIP and PCI-related myocardial injury with smaller sample size (n =
57) and cutoff point of PMR to be 1.3. We also investigated the associa-
tion between the presence of HIP and the incidence ofmyocardial injury
after PCI. A total of 77 patients with stable angina were imaged with
non-contrast T1WI by using a 1.5-T magnetic resonance system (HIP
and non-HIP group, N = 31 and 46 patients) [46]. We deﬁned HIP as a
signal intensity of coronary plaque to cardiac muscle ratio (PMR) of
≥1.4. High-sensitive cardiac troponin-T (hs-cTnT) was measured at
baseline and 24 h after PCI. HIP was associated with the characteristics
of ultrasound attenuation and positive remodeling on intravascular ul-
trasound. Although baseline hs-cTnT was similar between the groups,
increase of hs-cTnT was signiﬁcantly greater in the HIP versus non-HIP
group (0.065 [0.023–0.304] vs 0.017 [0.005–0.026], P b 0.001). PMI
(an elevation of hs-cTnT N5 × 99th percentile upper reference limit) oc-
curred more frequently in the HIP than non-HIP group (58.1% vs 10.9%,
P b 0.001), and the cut-off value of PMR found to be 1.44 for predictingImaging result Odds ratio
(95% CI)
.6%) CT value: 67.0 ± 10.1 (HU)
Ring-like appearance: 55.6%
0.96 (0.91–0.99)
n/a
) CT value: b50 (HU)
RI: 1.10 ± 0.21
Calciﬁcation: 33.7%
3.07 (1.48–6.35)
5%)
)
CT value: 43 (26.5–75.7)a (HU)
RI: 1.20 ± 0.18
Spotty (50%)
Ring-like appearance: 31%
4.54 (1.36–15.9)
4.27 (1.30–14.8)
CT value: 23.5 (9.5–40)a (HU)
RI: 1.5 (1.3–1.8)a
CPC (63%)
Ring-like appearance: 10%
0.977 (0.959–0.995)
79 (8–783)
CT value: b40 (HU)
RI: N1.05
Ring-like appearance: 36%
n/a
phy, TnT = troponin T, ULN = upper limit of normal, HU = Hounsﬁeld units, CPC =
Table 7
Coronary plaque characteristics on MRI for prediction of PMI.
Author Number of patients Events rate (%) Imaging results Odds ratio
(95% CI)
Asaumi et al. [45] 57
Transient no ﬂow (7.5%)
TnI N 5 × ULN (33.6%) HIP (PMR ≥ 1.3) 12.0 (3.2–52.2)
Hoshi et al. [46] 77
Slow ﬂow (15.6%)
TnT N 5 × ULN (29.8%) HIP (PMR ≥ 1.4) 5.63 (1.28–24.7)
Values are presented as mean ± SD except as noted.
PMI=periproceduralmyocardial infarction,MDCT=multi-detector computed tomography, TnT= troponin T, ULN=upper limit of normal, HIP=high intensity plaque, PMR=plaque
to cardiac muscle ratio.
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PMR ≥ 1.4 was a signiﬁcant predictor of PMI (odds ratio 5.63, 95% conﬁ-
dence interval 1.28–24.7, P = 0.022). HIP on non-contrast T1WI was
characterized as vulnerable coronary plaque on IVUS and was associat-
ed with higher incidence of PMI.
5. Clinical implications
Patel et al. has performed similar review regarding the comparison
on coronary imaging for prediction of PMI, and raised several discus-
sions about procedural safety and merit, modiﬁcation of PCI strategy
[47]. Intracoronary imaging is generally a safe procedure, and may
allow PCI optimization to reduce the risk of PMI from causes other
than distal embolization, such as side branchocclusion or incomplete le-
sion coverage. However, the low speciﬁcity of these modalities for the
prediction of distal embolization and PMI suggests that routine
intracoronary imaging may be a low-yield strategy. PMI is associated
with increased future mortality. The mechanisms and risk factors asso-
ciated with PMI vary. At present, there are more issues unanswered
than answered such as complexity of coronary lesions, prognosis, risk
stratiﬁcation and optimally management strategy related to PMI
event. Kini et al. were the ﬁrst to demonstrate the superiority of OCT-
deﬁned TCFA compared with other imaging modalities such as IVUS
andNIRS for prediction of PMI [33]. TheOCT-basedﬁbrous cap thickness
is themost important predictor of PMI. The CANARY trial demonstrated
that plaques responsible for PMI were lipid rich and had a large plaque
burden and a small MLA evaluated by NIRS, and the use of a distal em-
bolic protection ﬁlter did no reduce the rate of PMI after stenting of
lipid-rich plaques [34]. Therefore, the next step to prevent PMI would
be a trial comparing patients with the presence of OCT TCFA in the ves-
sel undergoing intervention randomized to either distal protection or
control.
Recently, noncontrast T1WI provided clinically and procedurally
important information on high-risk features of coronary plaques with-
out exposure to ionizing radiation and contrast media. Our study is
unique in detailed description of IVUS correlating with HIP on T1WI
and consequent clinical signiﬁcance [46]. The other step to prevent
PMI would be a trial comparing patient with the presence of HIP on
T1WI in the vessel undergoing intervention randomized to either distal
protection or control.
6. Medical treatment on PMI after PCI
Several therapeutic strategies, including statins, antithrombotic
agents [45] and b-blockers [46] have been suggested to reduce PMI.
The incidence of PMI has been reduced more effectively by high-dose
statin than by low-dose statin in statin-naive patients. Statins are
regarded as an important agent for the prevention of PMI. Takano
et al. [47] demonstrated that low-dose rosuvastatin was sufﬁcient for
patients who are already taking statins. A meta-analysis of Wang et al.
[48] demonstrated that in 24 RCTs with a total of 5526 patients, high-
dose statin pretreatment was associated with 59% relative reduction
in PMI (odds ratio [OR]: 0.41; 95% conﬁdence interval [CI]: 0.34–0.49;
P b 0.00001) and 39% relative reduction in MACE (OR: 0.61; 95% CI:0.45–0.83; P b 0.002). The beneﬁt of high-dose statin pretreatment on
MACE was signiﬁcant for statin-naive patients (OR: 0.69; 95% CI:
0.50–0.95; P b 0.02) and prior low dose statin-treated patients (OR:
0.28; 95% CI: 0.12–0.65; P b 0.003); and for patients with acute coronary
syndrome (OR: 0.52; 95% CI: 0.34–0.79; P b 0.003), but not for patients
with stable angina (OR: 0.71; 95% CI 0.45–1.10; P= 0.12).
7. Conclusion
With further improvements in imaging technology, invasive or non-
invasive coronary imaging becomes accurate detection of coronary
plaques in clinical practice. Assessment of both coronary stenosis and
plaque morphology has great potential application to further advance
the prediction of PMI. Further large studies will be needed to conﬁrm
that multi-modality imaging approach will become the gold standard
for evaluation of coronary plaque morphology predicting PMI in clinical
examinations.
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